Subscribe To
Novavax asks the fda to authorize its covid-19 vaccine candidate
Shares of Novavax Inc. NVAX, +8.37% rallied 10.0% in trading on Monday after the company said it filed for authorization of its experimental COVID-19 ...
January 31, 2022, 2:06 pm
Orasure said its rapid covid-19 tests can now be used in children
Shares of OraSure Technologies Inc. OSUR, +5.09% gained 2.2% in premarket trading on Monday after the company said its COVID-19 rapid tests have now b...
January 31, 2022, 7:54 am
Orasure said its rapid covid-19 tests can now be used in children
Shares of OraSure Technologies Inc. OSUR, +5.09% gained 2.2% in premarket trading on Monday after the company said its COVID-19 rapid tests have now b...
January 31, 2022, 7:54 am
Orasure said its rapid covid-19 tests can now be used in children
Shares of OraSure Technologies Inc. OSUR, +5.09% gained 2.2% in premarket trading on Monday after the company said its COVID-19 rapid tests have now b...
January 31, 2022, 7:54 am
Moderna began a clinical trial testing an omicron-specific vaccine booster shot in adults
Moderna CEO Stéphane Bancel previously projected the Omicron-specific vaccine booster to be available as early as this fall....
January 26, 2022, 6:18 pm
Moderna began a clinical trial testing an omicron-specific vaccine booster shot in adults
Moderna CEO Stéphane Bancel previously projected the Omicron-specific vaccine booster to be available as early as this fall....
January 26, 2022, 6:18 pm
Moderna began a clinical trial testing an omicron-specific vaccine booster shot in adults
Moderna CEO Stéphane Bancel previously projected the Omicron-specific vaccine booster to be available as early as this fall....
January 26, 2022, 6:18 pm
Abbvie: skyrizi and rinvoq latest fda approvals bode well for humira patent loss
Recent FDA approval for Skyrizi was obtained for the treatment of adults with active psoriatic arthriti...
January 25, 2022, 1:32 pm
Abbvie: skyrizi and rinvoq latest fda approvals bode well for humira patent loss
Recent FDA approval for Skyrizi was obtained for the treatment of adults with active psoriatic arthriti...
January 25, 2022, 1:32 pm
Abbvie: skyrizi and rinvoq latest fda approvals bode well for humira patent loss
Recent FDA approval for Skyrizi was obtained for the treatment of adults with active psoriatic arthriti...
January 25, 2022, 1:32 pm
Pfizer and biontech set to begin trials of omicron specific vaccine
Pfizer Inc (NYSE:PFE) and BioNTech say they have signed up the first participants for a clinical trial of a vaccine tailored to target the specific Om...
January 25, 2022, 11:07 am
Pfizer and biontech set to begin trials of omicron specific vaccine
Pfizer Inc (NYSE:PFE) and BioNTech say they have signed up the first participants for a clinical trial of a vaccine tailored to target the specific Om...
January 25, 2022, 11:07 am
Pfizer and biontech set to begin trials of omicron specific vaccine
Pfizer Inc (NYSE:PFE) and BioNTech say they have signed up the first participants for a clinical trial of a vaccine tailored to target the specific Om...
January 25, 2022, 11:07 am
Pfizer, biontech begin omicron-specific covid-19 vaccine study
COVID-19 vaccine-makers Pfizer and BioNTech announced Tuesday that the companies would test an omicron-specific vaccine candidate in healthy ...
January 25, 2022, 8:36 am
Pfizer, biontech begin omicron-specific covid-19 vaccine study
COVID-19 vaccine-makers Pfizer and BioNTech announced Tuesday that the companies would test an omicron-specific vaccine candidate in healthy ...
January 25, 2022, 8:36 am
Pfizer, biontech begin omicron-specific covid-19 vaccine study
COVID-19 vaccine-makers Pfizer and BioNTech announced Tuesday that the companies would test an omicron-specific vaccine candidate in healthy ...
January 25, 2022, 8:36 am
Merck's gefapixant for chronic cough slapped with fda complete response letter
The FDA has issued a Complete Response Letter (CRL) to Merck Co & Inc's (NYSE: MRK) gefapixant for refractory chronic cough (RCC) or unexplained c...
January 24, 2022, 7:14 am
Merck's gefapixant for chronic cough slapped with fda complete response letter
The FDA has issued a Complete Response Letter (CRL) to Merck Co & Inc's (NYSE: MRK) gefapixant for refractory chronic cough (RCC) or unexplained c...
January 24, 2022, 7:14 am
Merck's gefapixant for chronic cough slapped with fda complete response letter
The FDA has issued a Complete Response Letter (CRL) to Merck Co & Inc's (NYSE: MRK) gefapixant for refractory chronic cough (RCC) or unexplained c...
January 24, 2022, 7:14 am
Aslan pharma kickstarts mid-stage atopic dermatitis trial, data expected in 2023
ASLAN Pharmaceuticals Ltd (NASDAQ: ASLN) has screened the first patient in its Phase 2b dose-ranging study of eblasakimab (ASLAN004) in ...
January 21, 2022, 6:36 am